RegeneRx Biopharmaceuticals, Inc. (NYSEMKT:RGN)

CAPS Rating: No stars

The Company is a biopharmaceutical company that focuses on the discovery and development of novel molecules to accelerate tissue and organ repair.

No one has written a Pitch for RGN yet. Tell us why you think RGN will outperform or underperform the market.

Featured Broker Partners